BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 20081051)

  • 1. Roles of peroxisome proliferator-activated receptor-alpha and -gamma in the development of non-small cell lung cancer.
    Li MY; Yuan H; Ma LT; Kong AW; Hsin MK; Yip JH; Underwood MJ; Chen GG
    Am J Respir Cell Mol Biol; 2010 Dec; 43(6):674-83. PubMed ID: 20081051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pioglitazone prevents smoking carcinogen-induced lung tumor development in mice.
    Li MY; Kong AW; Yuan H; Ma LT; Hsin MK; Wan IY; Underwood MJ; Chen GG
    Curr Cancer Drug Targets; 2012 Jul; 12(6):597-606. PubMed ID: 22463586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 15-Lipoxygenases and its metabolites 15(S)-HETE and 13(S)-HODE in the development of non-small cell lung cancer.
    Yuan H; Li MY; Ma LT; Hsin MK; Mok TS; Underwood MJ; Chen GG
    Thorax; 2010 Apr; 65(4):321-6. PubMed ID: 20388757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PPARgamma activation extinguishes smoking carcinogen by inhibiting NNK-mediated proliferation.
    Li MY; Hsin MK; Yip J; Mok TS; Underwood MJ; Chen GG
    Am J Respir Cell Mol Biol; 2010 Jan; 42(1):113-22. PubMed ID: 19346318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined treatment with peroxisome proliferator-activated receptor (PPAR) gamma ligands and gamma radiation induces apoptosis by PPARγ-independent up-regulation of reactive oxygen species-induced deoxyribonucleic acid damage signals in non-small cell lung cancer cells.
    Han EJ; Im CN; Park SH; Moon EY; Hong SH
    Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):e239-48. PubMed ID: 23332223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antineoplastic effects of 15(S)-hydroxyeicosatetraenoic acid and 13-S-hydroxyoctadecadienoic acid in non-small cell lung cancer.
    Li MY; Yuan HL; Ko FW; Wu B; Long X; Du J; Wu J; Ng CS; Wan IY; Mok TS; Hui DS; Underwood MJ; Chen GG
    Cancer; 2015 Sep; 121 Suppl 17():3130-45. PubMed ID: 26331820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Up-regulation of p21 gene expression by peroxisome proliferator-activated receptor gamma in human lung carcinoma cells.
    Han S; Sidell N; Fisher PB; Roman J
    Clin Cancer Res; 2004 Mar; 10(6):1911-9. PubMed ID: 15041706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apoptotic action of peroxisome proliferator-activated receptor-gamma activation in human non small-cell lung cancer is mediated via proline oxidase-induced reactive oxygen species formation.
    Kim KY; Ahn JH; Cheon HG
    Mol Pharmacol; 2007 Sep; 72(3):674-85. PubMed ID: 17535976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peroxisome proliferator-activated receptor activity is involved in the osteoblastic differentiation regulated by bone morphogenetic proteins and tumor necrosis factor-α.
    Takano M; Otsuka F; Matsumoto Y; Inagaki K; Takeda M; Nakamura E; Tsukamoto N; Miyoshi T; Sada KE; Makino H
    Mol Cell Endocrinol; 2012 Jan; 348(1):224-32. PubMed ID: 21888945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peroxisome proliferator-activated receptor (PPAR)-gamma positively controls and PPARalpha negatively controls cyclooxygenase-2 expression in rat brain astrocytes through a convergence on PPARbeta/delta via mutual control of PPAR expression levels.
    Aleshin S; Grabeklis S; Hanck T; Sergeeva M; Reiser G
    Mol Pharmacol; 2009 Aug; 76(2):414-24. PubMed ID: 19483106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A rapid, homogeneous, fluorescence polarization binding assay for peroxisome proliferator-activated receptors alpha and gamma using a fluorescein-tagged dual PPARalpha/gamma activator.
    Seethala R; Golla R; Ma Z; Zhang H; O'Malley K; Lippy J; Cheng L; Mookhtiar K; Farrelly D; Zhang L; Hariharan N; Cheng PT
    Anal Biochem; 2007 Apr; 363(2):263-74. PubMed ID: 17335769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transgenic expression of mutant peroxisome proliferator-activated receptor gamma in liver precipitates fasting-induced steatosis but protects against high-fat diet-induced steatosis in mice.
    Tanaka T; Masuzaki H; Ebihara K; Ogawa Y; Yasue S; Yukioka H; Chusho H; Miyanaga F; Miyazawa T; Fujimoto M; Kusakabe T; Kobayashi N; Hayashi T; Hosoda K; Nakao K
    Metabolism; 2005 Nov; 54(11):1490-8. PubMed ID: 16253638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peroxisome proliferator-activated receptor-gamma ligands inhibit alpha5 integrin gene transcription in non-small cell lung carcinoma cells.
    Han S; Rivera HN; Roman J
    Am J Respir Cell Mol Biol; 2005 Apr; 32(4):350-9. PubMed ID: 15677767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peroxisome proliferator-activated receptor alpha and gamma ligands inhibit the growth of human ovarian cancer.
    Shigeto T; Yokoyama Y; Xin B; Mizunuma H
    Oncol Rep; 2007 Oct; 18(4):833-40. PubMed ID: 17786343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of peroxisome proliferator-activated receptor gamma in human cervical carcinoma.
    Jung TI; Baek WK; Suh SI; Jang BC; Song DK; Bae JH; Kwon KY; Bae JH; Cha SD; Bae I; Cho CH
    Gynecol Oncol; 2005 May; 97(2):365-73. PubMed ID: 15863131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential Effects of Estrogen Receptor Alpha and Beta on Endogenous Ligands of Peroxisome Proliferator-Activated Receptor Gamma in Papillary Thyroid Cancer.
    Yang S; Gong Z; Liu Z; Wei M; Xue L; Vlantis AC; Zhang Y; Chan JY; van Hasselt CA; Zeng X; Qiu S; Tang N; Du J; Wei W; Tong MC; Chen GG
    Front Endocrinol (Lausanne); 2021; 12():708248. PubMed ID: 34557159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective activation of PPARgamma in breast, colon, and lung cancer cell lines.
    Allred CD; Kilgore MW
    Mol Cell Endocrinol; 2005 May; 235(1-2):21-9. PubMed ID: 15866424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peroxisome proliferator-activated receptors in vascular biology-molecular mechanisms and clinical implications.
    Touyz RM; Schiffrin EL
    Vascul Pharmacol; 2006 Jul; 45(1):19-28. PubMed ID: 16782410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ligands for peroxisome proliferator-activated receptor gamma have potent antitumor effect against human renal cell carcinoma.
    Yuan J; Takahashi A; Masumori N; Uchida K; Hisasue S; Kitamura H; Itoh N; Tsukamoto T
    Urology; 2005 Mar; 65(3):594-9. PubMed ID: 15780399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peroxisome proliferator-activated receptor ligands regulate lipid content, metabolism, and composition in fetal lungs of diabetic rats.
    Kurtz M; Capobianco E; Careaga V; Martinez N; Mazzucco MB; Maier M; Jawerbaum A
    J Endocrinol; 2014 Mar; 220(3):345-59. PubMed ID: 24389592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.